海欣品牌怎么样 申请店铺

我要投票 海欣在毛绒玩具行业中的票数:208 更新时间:2025-04-26
海欣是哪个国家的品牌?「海欣」是 上海海欣集团股份有限公司 旗下著名品牌。该品牌发源于上海,由创始人皮展在1993期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力海欣品牌出海!通过在本页面挂载海欣品牌的产品链接和联系方式,可以提高海欣产品曝光!跨境电商爆单神器,目前只要100元/年哦~

海欣怎么样


上海海欣集团股份有限公司是一家以生产经营长毛绒产品为主,并已向医药产业和金融领域拓展的A、B股上市公司。前身为(中外合资)上海海欣有限公司,成立于1986年,1993年改制为股份公司。1993年12月和1994年4月,公司发行的B股和A股先后在上海证劵交易所上市。现为上海证劵交易所180指数样本股。

现在,公司的总股本约6亿股,其中B股约2亿股,A股约1.8亿股。总资产约33亿元人民币,净资产约18亿元人民币。

本公司进口日本原料从事研究开发长毛绒面料、涤纶和晴纶的纺丝/纱加工,及毛绒玩具、化纤毛毯、服装等相关纺织品生产,发展到现在的加工制造化学原料药物、生物制品、保健品、中药原料药和各类制剂等,并从事符合国家产业政策的投资业务和资产经营管理。

2002年企业加快了在全球范围内的优化资源配置步伐,抢滩北美,成功地收购了具有七十年历史的GLENOIT公司的纺织分部,及得到了46个可永久使用的品牌商标,并因此从亚洲毛绒生产大企业一跃成为世界毛绒生产巨头之一,在占全球60%服装市场的北美和加拿大占有一席之地。为此,企业主业之一的毛绒服装面料年生产能力已达到4000万米。目前以毛绒服装面料为主的产业已成为引导消费市场的国内骨干企业,设计配置多元化,正成为市场营销全球一体化的大型跨国企业,并计划迅速建立具有更大经济规模的服装生产企业,形成从面料到服装销售的品牌产品生产基地。

在医药领域,公司已投入近两亿元人民币,组建了海欣生物技术和西安华昊精英药业两家生物医药研发公司;投资设立了西安海欣制药、苏中海欣制药和赣南海欣药业三家医药生产企业;参股江苏苏中制药有限公司和上海延安万象药业股份有限公司,并控股上海生物技术工业园医药销售有限公司。形成了集研发、生产和销售三位一体的医药产业。医药产业正在成为公司重要利润的增长点之一。

在金融投资方面,公司以自有资金对长江证劵公司投资2.3亿元人民币,占其增资后的注册资本20亿元人民币的10%。本公司与长江证劵、武钢股份共同发起的长信基金管理有限公司已于2003年5月成立,注册资本9000万元人民币,其中,本公司出资占34.33%。

企业将来的经营目标是:保持经营业绩的持续稳步增长,进一步扩大纺织主业规模和市场占有率,加速调整公司产业结构;提高具有可观盈利空间的服装面料的比重,迅速发展壮大长毛绒服装产业,使之成为新的重要的利润增长点;加大纺织业新产品开发力度,提高新产品在销售额中的比重,积极拓展国内外纺织品市场;整合已具雏形的医药产业并取得可观的收益;根据公司跨行业、跨国经营的实际和发展要求,加强企业管理和企业文化建设。探索跨行业、跨地区的国际化企业集团管理模式;在主营业务收入和净利润等方面保持稳步的增长。未来五年,力争企业建设及规模从净资产18亿人民币增加到30亿元人民币;年净利润总额从1.57亿提高到3.5亿元人民币,形成精品纺织、生物医药和金融投资三位一体的多元化产业发展格局。


Shanghai Haixin Group Co., Ltd. is a listed company of a and B shares, which mainly produces and operates long plush products and has expanded to the pharmaceutical industry and financial field. The former is (Sino foreign joint venture) Shanghai Haixin Co., Ltd., which was founded in 1986 and restructured into a joint stock company in 1993. In December 1993 and April 1994, B shares and a shares issued by the company were listed on the Shanghai Stock Exchange successively. Now it is the sample stock of Shanghai Stock Exchange 180 index. At present, the total share capital of the company is about 600 million shares, including about 200 million B shares and about 180 million a shares. The total assets are about 3.3 billion yuan, and the net assets are about 1.8 billion yuan. The company imports Japanese raw materials to engage in the research and development of the spinning / yarn processing of plush fabrics, polyester and acrylic fiber, and the production of plush toys, chemical fiber blankets, clothing and other related textiles, and develops to the present processing and manufacturing of chemical raw materials drugs, biological products, health products, traditional Chinese medicine raw materials and various preparations, and engaged in investment business and asset management in line with national industrial policies 。 In 2002, the company accelerated the pace of optimizing resource allocation in the global scope, seized North America, successfully acquired the textile division of glonoit company with a history of 70 years, and obtained 46 brand trademarks that can be permanently used. Therefore, the company has become one of the world's largest plush producers from the Asian plush production enterprises, occupying one in North America and Canada, accounting for 60% of the global clothing market Place of seats. Therefore, the annual production capacity of plush clothing fabric, one of the main businesses of the enterprise, has reached 40 million meters. At present, the industry dominated by plush clothing fabrics has become a domestic backbone enterprise guiding the consumer market. With diversified design and configuration, it is becoming a large-scale transnational enterprise with global marketing integration. It is planned to rapidly establish a clothing production enterprise with a larger economic scale and form a production base of brand products from fabrics to clothing sales. In the field of medicine, the company has invested nearly 200 million yuan to establish two biomedical R & D companies: Haixin biotechnology and Xi'an Huahao elite pharmaceutical industry; three pharmaceutical production companies, Xi'an Haixin pharmaceutical, Suzhong Haixin pharmaceutical and Gannan Haixin pharmaceutical, have been invested and established; jiangsusu Pharmaceutical Co., Ltd. and Shanghai Yan'an Vientiane Pharmaceutical Co., Ltd. have been invested and controlled by Shanghai Sheng Pharmaceutical Sales Co., Ltd. of the material technology industrial park. It has formed a pharmaceutical industry integrating R & D, production and sales. The pharmaceutical industry is becoming one of the important profit growth points of the company. In terms of financial investment, the company invested 230 million yuan in Changjiang Securities Company with its own funds, accounting for 10% of its registered capital of 2 billion yuan after capital increase. Changxin Fund Management Co., Ltd., jointly sponsored by the company, Changjiang Securities and WISCO, was established in May 2003 with a registered capital of 90 million yuan, of which 34.33% was invested by the company. The future business objectives of the enterprise are: to maintain the sustained and steady growth of business performance, to further expand the scale and market share of the main textile industry, to accelerate the adjustment of the company's industrial structure; to increase the proportion of clothing fabrics with considerable profit space, to rapidly develop and expand the plush clothing industry, to make it a new important profit growth point; to increase the development of new products in the textile industry, and to improve The proportion of high-tech products in sales volume, actively expand the domestic and foreign textile market; integrate the rudimentary pharmaceutical industry and make considerable profits; strengthen enterprise management and corporate culture construction according to the actual and development requirements of cross industry and transnational operation of the company. Explore the management mode of international enterprise groups across industries and regions, and maintain a steady growth in the main business income and net profit. In the next five years, we will strive to increase the construction and scale of enterprises from 1.8 billion yuan in net assets to 3 billion yuan; increase the total annual net profit from 157 million yuan to 350 million yuan, and form a diversified industrial development pattern integrating fine textile, biomedicine and financial investment.

本文链接: https://brand.waitui.com/59cefcfd9.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

习近平在中共中央政治局第二十次集体学习时强调,坚持自立自强,突出应用导向,推动人工智能健康有序发展

中共中央政治局4月25日下午就加强人工智能发展和监管进行第二十次集体学习。中共中央总书记习近平在主持学习时强调,面对新一代人工智能技术快速演进的新形势,要充分发挥新型举国体制优势,坚持自立自强,突出应用导向,推动我国人工智能朝着有益、安全、公平方向健康有序发展。(新华社)

10分钟前

上海经信委:将推动整车企业转型,加强智能驾驶大模型等创新应用

“智链未来 共赢新章”2025年长三角新能源汽车产业链供应链创新合作大会于4月25日在国家会展中心(上海)召开。上海市经信委二级巡视员、汽车产业处处长韩大东在会上致辞时表示,汽车产业是上海的重点产业之一。在当前全球汽车产业变革调整窗口期、机遇期,上海全力破解汽车产业转型升级的痛点、堵点,加快打造世界级汽车产业中心,推动长三角一体化发展,近年来取得了一定成效。 韩大东强调,当前,全球汽车竞争格局向电动化、智能化、AI化发展,零部件一体化、集成化、轻量化趋势明显。叠加国际贸易摩擦、关税壁垒等地缘政治影响,汽车产业链面临重塑与变革。为加快提升长三角地区汽车产业全链条竞争力,上海将推动整车企业改革转型,加强智能驾驶大模型等创新技术应用,加快智己、奥迪、尚界等新车型投产上市,促进长三角地区及全国汽车产业链上下游协同发展。(澎湃新闻)

10分钟前

炮制假非遗、AI生成假神医,涉事企业被立案调查

4月25日,总台中国之声报道电商平台热销的养生贴“苗古金贴”涉嫌虚假宣传。该产品号称由传承“千年秘方”的非遗传承人制作,该传承人实为AI生成,产品页面展示的“非遗传承人”证书为机构非法制作。 针对有关违法线索,厦门市市场监管局快速反应,集美区市场监管局第一时间组织精干力量前往涉事企业现场,连夜开展核查处置。经初步核查,报道中涉及的是厦门追尖科技有限公司、厦门乐土网络科技有限公司、苗古金贴(厦门)大药房有限公司等企业。目前查到以上企业在淘宝、京东、拼多多、抖音等平台共计开设9家网店,主要销售“苗古金贴颈椎贴”等医疗器械产品。 执法人员现场检查涉事网店,发现店铺在售商品详情页面有宣传“非遗传承人”“千年苗方”“专供颈椎问题”等字样,部分店铺销量显示“已拼500万+件”“已售60万+”等数据。执法人员已当场对相关证据进行提取固定,责令当事人将上述产品链接全部下架处置。集美区局依法依规对当事人涉嫌虚假宣传、刷单等违法行为立案调查,对制作假证等违法线索移送相关部门。(央视新闻)

10分钟前

新华时评:用好用足更加积极的财政政策 要确保财政资金的“真金白银”加快落地、落到实地

新华时评26日发布评论文章《首季中国经济观察|用好用足更加积极的财政政策》。文章指出,用好用足更加积极的财政政策,要确保财政资金的“真金白银”加快落地、落到实地。持续提高财政资金配置效率和使用效益,优化支出结构、强化绩效管理,让每一分钱都花在国计民生关键处。“能否有效将资金用在刀刃上”应成为检验相关部门工作的一把标尺,持续加强对政策实施情况的动态评估,不断完善激励机制,充分调动基层的积极性和主动性,确保政策落地落实、资金切实惠企利民。(财联社)

10分钟前

央行行长潘功胜会见世界银行行长彭安杰

中国人民银行行长潘功胜4月25日在出席国际货币基金组织/世界银行春季会议期间会见了世界银行行长彭安杰,双方就中国人民银行与世界银行合作等议题交换了意见。潘功胜指出,当前世界经济不稳定不确定性上升,单边主义、保护主义严重损害国际经贸秩序,对全球经济造成巨大负面影响。面对外部环境冲击,中国政府实施适度宽松的货币政策和更加积极的财政政策,经济延续回升向好态势。潘功胜强调,世界银行作为重要的多边合作平台,为促进全球合作发展发挥着重要作用。中国人民银行愿与世界银行进一步深化务实金融合作,继续践行真正的多边主义,共促全球经济发展。(财联社)

10分钟前

本页详细列出关于海欣的品牌信息,含品牌所属公司介绍,海欣所处行业的品牌地位及优势。
咨询